000170133 001__ 170133
000170133 005__ 20240229133706.0
000170133 0247_ $$2doi$$a10.1007/s00401-021-02356-6
000170133 0247_ $$2pmid$$apmid:34355256
000170133 0247_ $$2ISSN$$a0001-6322
000170133 0247_ $$2ISSN$$a1432-0533
000170133 0247_ $$2altmetric$$aaltmetric:111276848
000170133 037__ $$aDKFZ-2021-01763
000170133 041__ $$aEnglish
000170133 082__ $$a610
000170133 1001_ $$0P:(DE-He78)8aad075b17d93a5636a34942bdbd7ee6$$aSievers, Philipp$$b0$$eFirst author$$udkfz
000170133 245__ $$aRecurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
000170133 260__ $$aHeidelberg$$bSpringer$$c2021
000170133 3367_ $$2DRIVER$$aarticle
000170133 3367_ $$2DataCite$$aOutput Types/Journal article
000170133 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642411829_3273
000170133 3367_ $$2BibTeX$$aARTICLE
000170133 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000170133 3367_ $$00$$2EndNote$$aJournal Article
000170133 500__ $$a#EA:B300#LA:B300# / 2021 Nov;142(5):827-839
000170133 520__ $$aEpendymomas encompass a heterogeneous group of central nervous system (CNS) neoplasms that occur along the entire neuroaxis. In recent years, extensive (epi-)genomic profiling efforts have identified several molecular groups of ependymoma that are characterized by distinct molecular alterations and/or patterns. Based on unsupervised visualization of a large cohort of genome-wide DNA methylation data, we identified a highly distinct group of pediatric-type tumors (n = 40) forming a cluster separate from all established CNS tumor types, of which a high proportion were histopathologically diagnosed as ependymoma. RNA sequencing revealed recurrent fusions involving the pleomorphic adenoma gene-like 1 (PLAGL1) gene in 19 of 20 of the samples analyzed, with the most common fusion being EWSR1:PLAGL1 (n = 13). Five tumors showed a PLAGL1:FOXO1 fusion and one a PLAGL1:EP300 fusion. High transcript levels of PLAGL1 were noted in these tumors, with concurrent overexpression of the imprinted genes H19 and IGF2, which are regulated by PLAGL1. Histopathological review of cases with sufficient material (n = 16) demonstrated a broad morphological spectrum of tumors with predominant ependymoma-like features. Immunohistochemically, tumors were GFAP positive and OLIG2- and SOX10 negative. In 3/16 of the cases, a dot-like positivity for EMA was detected. All tumors in our series were located in the supratentorial compartment. Median age of the patients at the time of diagnosis was 6.2 years. Median progression-free survival was 35 months (for 11 patients with data available). In summary, our findings suggest the existence of a novel group of supratentorial neuroepithelial tumors that are characterized by recurrent PLAGL1 fusions and enriched for pediatric patients.
000170133 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000170133 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000170133 650_7 $$2Other$$aEP300
000170133 650_7 $$2Other$$aEWSR1
000170133 650_7 $$2Other$$aFOXO1
000170133 650_7 $$2Other$$aGene fusion
000170133 650_7 $$2Other$$aNeuroepithelial tumor
000170133 650_7 $$2Other$$aPLAGL1
000170133 650_7 $$2Other$$aSupratentorial
000170133 7001_ $$0P:(DE-He78)e2284d7dd74e9551b01bac75c28bcdd3$$aHenneken, Sophie$$b1$$eFirst author$$udkfz
000170133 7001_ $$0P:(DE-He78)a4d58b3605bb0818ae8e3092b8c35182$$aBlume, Christina$$b2$$udkfz
000170133 7001_ $$0P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aSill, Martin$$b3$$udkfz
000170133 7001_ $$0P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aSchrimpf, Daniel$$b4$$udkfz
000170133 7001_ $$0P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aStichel, Damian$$b5$$udkfz
000170133 7001_ $$0P:(DE-He78)34b3639de467b2c700920d7cbc3d2110$$aOkonechnikov, Konstantin$$b6$$udkfz
000170133 7001_ $$0P:(DE-He78)d5149ffd74f42a2fa87a086d66645aaa$$aReuss, David E$$b7$$udkfz
000170133 7001_ $$0P:(DE-He78)2b12a7cfc604eb9816670e995f7af508$$aBenzel, Julia$$b8$$udkfz
000170133 7001_ $$0P:(DE-HGF)0$$aMaaß, Kendra K$$b9
000170133 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b10$$udkfz
000170133 7001_ $$0P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aSturm, Dominik$$b11$$udkfz
000170133 7001_ $$0P:(DE-He78)1d5e6252296473fc060b71e61a22256c$$aZheng, Tuyu$$b12$$udkfz
000170133 7001_ $$0P:(DE-HGF)0$$aGhasemi, David R$$b13
000170133 7001_ $$aKohlhof-Meinecke, Patricia$$b14
000170133 7001_ $$aCruz, Ofelia$$b15
000170133 7001_ $$aSuñol, Mariona$$b16
000170133 7001_ $$aLavarino, Cinzia$$b17
000170133 7001_ $$aRuf, Viktoria$$b18
000170133 7001_ $$aBoldt, Henning B$$b19
000170133 7001_ $$aPagès, Mélanie$$b20
000170133 7001_ $$aPouget, Celso$$b21
000170133 7001_ $$0P:(DE-He78)db2e8cf0dd8fa826896839ffee4b1411$$aSchweizer, Leonille$$b22$$udkfz
000170133 7001_ $$aKranendonk, Mariëtte E G$$b23
000170133 7001_ $$aAkhtar, Noreen$$b24
000170133 7001_ $$aBunkowski, Stephanie$$b25
000170133 7001_ $$aStadelmann, Christine$$b26
000170133 7001_ $$aSchüller, Ulrich$$b27
000170133 7001_ $$aMueller, Wolf C$$b28
000170133 7001_ $$aDohmen, Hildegard$$b29
000170133 7001_ $$aAcker, Till$$b30
000170133 7001_ $$0P:(DE-He78)b15b56a6ed37417d476470c60c0140ff$$aHarter, Patrick$$b31
000170133 7001_ $$aMawrin, Christian$$b32
000170133 7001_ $$aBeschorner, Rudi$$b33
000170133 7001_ $$aBrandner, Sebastian$$b34
000170133 7001_ $$aSnuderl, Matija$$b35
000170133 7001_ $$aAbdullaev, Zied$$b36
000170133 7001_ $$aAldape, Kenneth$$b37
000170133 7001_ $$aGilbert, Mark R$$b38
000170133 7001_ $$aArmstrong, Terri S$$b39
000170133 7001_ $$aEllison, David W$$b40
000170133 7001_ $$0P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aCapper, David$$b41$$udkfz
000170133 7001_ $$aIchimura, Koichi$$b42
000170133 7001_ $$0P:(DE-HGF)0$$aReifenberger, Guido$$b43
000170133 7001_ $$aGrundy, Richard G$$b44
000170133 7001_ $$aJabado, Nada$$b45
000170133 7001_ $$aKrskova, Lenka$$b46
000170133 7001_ $$aZapotocky, Michal$$b47
000170133 7001_ $$aVicha, Ales$$b48
000170133 7001_ $$aVarlet, Pascale$$b49
000170133 7001_ $$aWesseling, Pieter$$b50
000170133 7001_ $$aRutkowski, Stefan$$b51
000170133 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b52$$udkfz
000170133 7001_ $$0P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee$$aWick, Wolfgang$$b53$$udkfz
000170133 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b54$$udkfz
000170133 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David T W$$b55$$udkfz
000170133 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, Andreas$$b56$$udkfz
000170133 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian W$$b57$$eLast author$$udkfz
000170133 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b58$$eLast author$$udkfz
000170133 773__ $$0PERI:(DE-600)1458410-4$$a10.1007/s00401-021-02356-6$$n5$$p827-839$$tActa neuropathologica$$v142$$x1432-0533$$y2021
000170133 909CO $$ooai:inrepo02.dkfz.de:170133$$pVDB
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8aad075b17d93a5636a34942bdbd7ee6$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e2284d7dd74e9551b01bac75c28bcdd3$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a4d58b3605bb0818ae8e3092b8c35182$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)34b3639de467b2c700920d7cbc3d2110$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d5149ffd74f42a2fa87a086d66645aaa$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2b12a7cfc604eb9816670e995f7af508$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1d5e6252296473fc060b71e61a22256c$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)db2e8cf0dd8fa826896839ffee4b1411$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b15b56a6ed37417d476470c60c0140ff$$aDeutsches Krebsforschungszentrum$$b31$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aDeutsches Krebsforschungszentrum$$b41$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b43$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b52$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee$$aDeutsches Krebsforschungszentrum$$b53$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b54$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b55$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b56$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b57$$kDKFZ
000170133 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b58$$kDKFZ
000170133 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000170133 9141_ $$y2021
000170133 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-29$$wger
000170133 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-29$$wger
000170133 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACTA NEUROPATHOL : 2019$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-29
000170133 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bACTA NEUROPATHOL : 2019$$d2021-01-29
000170133 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x0
000170133 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000170133 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x2
000170133 9201_ $$0I:(DE-He78)B240-20160331$$kB240$$lB240 Bioinformatik und Omics Data Analytics$$x3
000170133 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x4
000170133 9201_ $$0I:(DE-He78)BE01-20160331$$kBE01$$lDKTK BE zentral$$x5
000170133 9201_ $$0I:(DE-He78)FM01-20160331$$kFM01$$lDKTK FM zentral$$x6
000170133 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK ED ES zentral$$x7
000170133 9201_ $$0I:(DE-He78)B320-20160331$$kB320$$lKKE Neuroonkologie$$x8
000170133 980__ $$ajournal
000170133 980__ $$aVDB
000170133 980__ $$aI:(DE-He78)B300-20160331
000170133 980__ $$aI:(DE-He78)HD01-20160331
000170133 980__ $$aI:(DE-He78)B062-20160331
000170133 980__ $$aI:(DE-He78)B240-20160331
000170133 980__ $$aI:(DE-He78)B360-20160331
000170133 980__ $$aI:(DE-He78)BE01-20160331
000170133 980__ $$aI:(DE-He78)FM01-20160331
000170133 980__ $$aI:(DE-He78)ED01-20160331
000170133 980__ $$aI:(DE-He78)B320-20160331
000170133 980__ $$aUNRESTRICTED